The Healthcare Compliance Blog
Bi-weekly editorial digests covering the most important regulatory developments, compliance trends, and practice growth strategies across all 50 states.
Telehealth Tensions: Navigating DEA Scrutiny, CPOM Landmines, and State Board Enforcement in a Post-PHE World
The healthcare regulatory landscape continues its rapid evolution, presenting both opportunities and significant compliance challenges. This week's digest unpacks critical developments from the DEA, DOJ, and state boards, highlighting increased scrutiny on telehealth prescribing, the enduring complexities of Corporate Practice of Medicine doctrines, and what these mean for your practice's operational integrity and growth strategy.
Telehealth's Tightening Grip: DEA, DOJ, and State Boards Signal a New Era of Scrutiny
The healthcare compliance landscape is rapidly evolving, with federal agencies and state boards intensifying their focus on telehealth, controlled substance prescribing, and corporate practice of medicine. This week's digest unpacks critical enforcement trends and regulatory shifts that demand immediate attention from healthcare executives.
Medspa Expansion: Navigating the Regulatory Minefield for Compliant Growth
Expanding a medspa operation promises significant revenue growth, but the regulatory landscape is fraught with complexities. This guide offers a compliance-first roadmap for scaling your medspa, ensuring sustainable growth while mitigating critical legal and operational risks.
Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State
Michigan presents a dynamic yet challenging regulatory environment for healthcare businesses, particularly in the rapidly evolving telehealth and medspa sectors. From strict corporate practice of medicine doctrines to heightened medical board scrutiny, understanding the Wolverine State's unique compliance landscape is critical for sustainable operations and avoiding significant enforcement risks.
GLP-1 Telehealth: Navigating the Regulatory Minefield of Rapid Growth
The explosion of GLP-1 agonists for weight loss has ignited a new frontier in telehealth, promising unprecedented access but also attracting intense regulatory scrutiny. This analysis dissects the complex compliance challenges, from prescribing controlled substances to navigating corporate practice of medicine doctrines, charting a course for sustainable growth in this high-stakes sector.
Navigating the Minefield: CPOM Compliance for Multi-State Telehealth and Medspa Operations in 2025-2026
The Corporate Practice of Medicine (CPOM) doctrine remains a formidable challenge for healthcare businesses, particularly those expanding telehealth and medspa services across state lines. This deep dive unpacks the nuances of CPOM, offering actionable strategies to build compliant, scalable models in a complex regulatory environment.
The Compliance Crucible: Navigating Intensified Scrutiny in Telehealth, Medspas, and Controlled Substance Prescribing
The regulatory landscape for healthcare businesses is intensifying, with federal and state agencies sharpening their focus on telehealth, medspas, and controlled substance prescribing. This roundup dissects recent enforcement actions, new rules, and critical guidance, offering actionable insights for navigating this complex environment.
Navigating the New Regulatory Frontier: DEA Crackdowns, CPOM Scrutiny, and State-Specific Telehealth Compliance
The healthcare regulatory landscape is shifting dramatically, with intensified enforcement from the DEA, heightened scrutiny of Corporate Practice of Medicine doctrines, and granular state-specific telehealth rules. For telehealth innovators and expanding practices, understanding these converging pressures is no longer optional—it's foundational to sustainable growth.
Navigating the Regulatory Gauntlet: CPOM, Controlled Substances, and Telehealth's Evolving Landscape
The healthcare regulatory landscape is in constant flux, presenting both opportunities and formidable challenges for telehealth, medspas, and expanding practices. This digest cuts through the noise, revealing critical trends in Corporate Practice of Medicine, controlled substance prescribing, and state-specific telehealth rules that demand your immediate attention.
Never Miss a Compliance Update
Join healthcare leaders who rely on our bi-weekly digest to stay ahead of regulatory changes across all 50 states.